男性隐匿性乳腺癌一例并文献复习 - betway必威登陆网址

国际肿瘤学杂志››2020,Vol. 47››Issue (1): 60-61.doi:10.3760/cma.j.issn.1673-422X.2020.01.012

• 病例报道 •上一篇下一篇

男性隐匿性乳腺癌一例并文献复习

郭术楠, 汪庚明()

蚌埠医学院第一附属医院肿瘤放疗科 233000

收稿日期:2019-11-11修回日期:2019-12-26出版日期:2020-01-08发布日期:2020-03-22
通讯作者:汪庚明 E-mail:lansefeidian777@163.com
基金资助:
安徽省临床医学优先发展重点专科(卫科教2018-291)

Received:2019-11-11Revised:2019-12-26Online:2020-01-08Published:2020-03-22

摘要/Abstract

摘要：

男性乳腺癌占所有乳腺癌的1%,隐匿性乳腺癌的发病率约占同期乳腺癌总发病率的0.3%~1%。现报道1例男性隐匿性乳腺癌,以增加对男性隐匿性乳腺癌的认识,避免因误诊延误治疗。

郭术楠, 汪庚明. 男性隐匿性乳腺癌一例并文献复习[J]. 国际肿瘤学杂志, 2020, 47(1): 60-61.

图/表3

参考文献13

[1]	陆苏, 刘红 . 44例隐匿性乳腺癌临床分析[J]. 中华肿瘤杂志, 2011,33(7):550-552. DOI: 10.3760/cma.j.issn.0253-3766.2011.07.018.
[2]	Halsted WS . The results of radical operations for the cure of carcinoma of the breast[J]. Ann Surg, 1907,46(1):1-19. DOI: 10.1097/00000658-190707000-00001.
[3]	Lu H, Xu YL, Zhang SP , et al. Breast magnetic resonance imaging in patients with occult breast carcinoma: evaluation on feasibility and correlation with histopathological findings[J]. Chin Med J (Engl), 2011,124(12):1790-1795. DOI: 10.3760/cma.j.issn.0366-6999.
[4]	李小康, 徐熠琳, 刘佩芳 , 等. 乳腺MRI在X线检查乳腺阴性腋淋巴结转移癌阳性患者中的应用价值[J]. 中华放射学杂志, 2011,45(4):348-352. DOI: 10.3760/cma.j.issn.1005-1201.2011.04.006.
[5]	Maselli-Schoueri JH, Affonso-Kaufman FA, de Melo Sette CV, , et al. Time trend of breast cancer mortality in BRAZILIAN men: 10-year data analysis from 2005 to 2015[J]. BMC Cancer, 2019,19(1):23. DOI: 10.1186/s12885-018-5261-1.
[6]	Agbroko SO, Rojas KE, Manasseh DM , et al. Male DCIS diagnosed after use of over-the-counter hormonal supplement[J]. Int J Surg Case Rep, 2019,57:60-62. DOI: 10.1016/j.ijscr.2019.02.028.
[7]	Barghouthi N, Turner J, Perini J , et al. Breast cancer development in a transgender male receiving testosterone therapy[J]. Case Rep Endocrinol, 2018,2018:602. DOI: 10.1155/2018/3652602.
[8]	Rizzolo P, Zelli V, Silvestri V , et al. Insight into genetic susceptibility to male breast cancer by multigene panel testing: results from a multicenter study in Italy[J]. Int J Cancer, 2019,145(2):390-400. DOI: 10.1002/ijc.32106.
[9]	马家芳, 乔昱, 丁丽 , 等. 男性乳腺癌患者临床病理特征及诊治分析[J]. 中华老年医学杂志, 2015,34(7):790-792. DOI: 10.3760/cma.j.issn.0254-9026.2015.07.026.
[10]	Xu R, Li J, Zhang Y , et al. Male occult breast cancer with axillary lymph node metastasis as the first manifestation[J]. Medicine (Baltimore), 2017,96(51):e9312. DOI: 10.1097/MD.00000000-00009312.
[11]	Ruddy KJ, Winer EP . Male breast cancer: risk factors, biology, diagnosis, treatment, and survivorship[J]. Ann Oncol, 2013,24(6):1434-1443. DOI: 10.1093/annonc/mdt025.
[12]	Bateni SB, Davidson AJ, Arora M , et al. Is breast-conserving therapy appropriate for male breast cancer patients? A national cancer database analysis[J]. Ann Surg Oncol, 2019,26(7):2144-2153. DOI: 10.1245/s10434-019-07159-4.
[13]	Wei JL, Zhang JX, Fu DY , et al. Characterization and prognosis of estrogen receptor-positive/progesterone receptor-negative male breast cancer: a population-based study[J]. World J Surg Oncol, 2018,16(1):236. DOI: 10.1186/s12957-018-1539-7.

相关文章15

编辑推荐

Metrics

本文评价